Global Diabetes Trends and Treatment Gaps: 1990-2022 Analysis

Regional Variations in Diabetes Prevalence and Treatment

The largest increases in diabetes rates were observed in low- and middle-income countries (LMICs), where the disease burden has significantly risen. In contrast, regions like North America, Australasia, central and western Europe, and parts of Latin America and East Asia and the Pacific have seen improvements in diabetes treatment rates, contributing to widening global inequities in diabetes treatment.

Policy Implications

The findings emphasize the urgent need for financing of medicines and comprehensive diabetes programs to enable early detection and effective treatment of diabetes, particularly in LMICs. Overall, the study underscores the growing global burden of diabetes, especially in low-income regions, and highlights the critical need for improved access to diabetes treatment and care.

Semaglutide NAION Risk: EMA Review Initiated Amid Conflicting Evidence

January 21, 2025 João L. Carapinha

🔍 Is semaglutide linked to vision loss?

The European Medicines Agency’s PRAC is currently reviewing the potential risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with semaglutide-containing medicines, including popular treatments like Ozempic and Wegovy. With recent studies yielding conflicting evidence, this review is crucial for patient safety and the future of these therapies.

Read the full article to understand the implications and what this could mean for healthcare providers and patients alike!

#SyenzaNews #Pharmaceuticals #HealthcarePolicy

Cost-Effective Cervical Cancer Screening Strategies for Women with HIV in KwaZulu-Natal

January 20, 2025 Rene Pretorius

💡 *Are single-visit cervical cancer screenings the key to better health outcomes in high HIV prevalence areas?*
A recent study from KwaZulu-Natal, South Africa reveals that repeat single-visit cervical cancer screening using HPV DNA testing is not only the most effective but also the most cost-effective approach for women living with HIV. This aligns with WHO recommendations for comprehensive cervical cancer elimination strategies.

Explore the insights and implications of this vital research that could transform cervical cancer prevention in resource-limited settings.

#SyenzaNews #HealthEconomics #oncology #GlobalHealth

Advancing EU Health Technology Assessment: Insights from the HAG Meeting

January 20, 2025 João L. Carapinha

💡 How can the EU Health Technology Assessment reshape healthcare delivery?

The recent meeting of the Heads of HTA Agencies Group heralds a new era with the operationalization of the EU’s Health Technology Assessment Regulation, aiming to streamline processes and enhance collaboration across member states.

This initiative promises to improve data transparency, foster innovative health technologies, and ultimately, drive better patient outcomes.

Curious to learn more about these significant updates and what they mean for the future of health assessments in the EU? Jump into the full article!

#SyenzaNews #HealthTech #HealthEconomics #DigitalTransformation